术中丝裂霉素C在复发性视网膜脱离合并增生性玻璃体视网膜病变中的应用:含对照组的比较研究
该回顾性比较研究纳入2022至2024年间因复发性孔源性视网膜脱离(RRD)合并增生性玻璃体视网膜病变(PVR)接受玻璃体切除术(PPV)的60例患者,分为MMC组(n=30)与对照组(n=30)。两组在视网膜复位率、PVR发生及视力改善方面相近,差异均无统计学意义;作者认为MMC或与更有利的解剖结局相关,但需更大样本前瞻性研究证实。
要点
- MMC组主要解剖成功率83.3%,对照组70.0%,差异未达统计学意义。
- MMC组继发解剖成功率50.0%,对照组46.7%,两组相近。
- 两组术后视力均显著改善,但组间无显著差异。
核心结论
- 在复发性RRD合并PVR患者中,术中应用MMC与更有利的解剖结局和并发症情况相关,但缺乏统计学显著性,需谨慎解读。
研究设计与样本
- 回顾性比较研究,纳入2022至2024年间因复发性RRD合并PVR手术的60例患者,MMC组30例、对照组30例,均行PPV。
主要发现
- 主要解剖成功率(最终术后视网膜复位且眼压高于6 mmHg)MMC组83.3%、对照组70.0%。
- 继发解剖成功率(成功取出硅油且无再脱离或无需进一步干预)MMC组50.0%、对照组46.7%。
- 两组术后视力均较术前显著改善,但组间无显著差异。
- MMC组PVR发生率较低,但差异未达统计学意义。
临床怎么用
- 对复发性RRD合并PVR行PPV时可考虑辅助应用MMC,但现有证据尚不足以确立其常规地位。
局限性
- 为回顾性设计,样本量60例较小,主要结局差异未达统计学意义,需更大样本前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to evaluate the impact of intraoperative mitomycin-C (MMC) application during pars plana vitrectomy (PPV) on anatomical success, the need for additional surgery, and visual outcomes in patients with recurrent rhegmatogenous retinal detachment (RRD) associated with proliferative vitreoretinopathy (PVR) following previous retinal surgery. METHODS: This retrospective comparative study included 60 patients who underwent surgery for recurrent RRD with PVR between 2022 and 2024. Patients were divided into an MMC-treated group (n=30) and a control group (n=30). All patients underwent PPV, and outcomes including anatomical and functional success, silicone oil removal, and additional surgical interventions were compared between groups. RESULTS: Rates of retinal reattachment, PVR development, and functional improvement were comparable between groups. The primary anatomical success rate-defined as retinal reattachment with intraocular pressure above 6 mmHg at final postoperatively-was 83.3% in the MMC group and 70.0% in the control group. Secondary anatomical success-defined as successful silicone oil removal without redetachment or need for further intervention-was achieved in 50.0% and 46.7% of patients, respectively. Both groups showed statistically significant postoperative improvements in visual acuity; however, no significant difference was observed between them. Although the incidence of PVR was lower in the MMC group, the difference did not reach statistical significance. CONCLUSION: Although MMC use was associated with more favorable anatomical outcomes and complication profiles in recurrent RRD cases, the lack of statistical significance warrants cautious interpretation, and larger prospective studies are needed to confirm its potential benefit as an adjuvant therapy.
引用
- Avcı E, Özal E, Ermiş S, et al. Intraocular Mitomycin-C in the Management of Recurrent Retinal Detachment and Proliferative Vitreoretinopathy: A Comparative Study With a Control Group. Retina. 2026. PMID: 42765887. doi:10.1097/IAE.0000000000005019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。